Clinical Trials Sponsored by Calithera Biosciences, Inc
Total 711 results
-
Calithera Biosciences, IncTerminatedNon-GCB/ABC Diffuse Large B-Cell Lymphoma | With and Without MyD88 and/or CD79B MutationsUnited States
-
Calithera Biosciences, IncCompleted
-
Calithera Biosciences, IncWithdrawnAdvanced Solid Neoplasms | Lymphoma Neoplasms
-
Calithera Biosciences, IncCompletedAdvanced Solid TumorsUnited States
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Squamous Non-small-cell Lung Cancer | NFE2L2 Gene Mutation | Squamous Non-Small Cell Neoplasm of LungUnited States
-
Calithera Biosciences, IncTerminatedMelanoma | Non-small Cell Lung Cancer (NSCLC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NFE2L2 Gene Mutation | NRF2 MutationUnited States
-
Calithera Biosciences, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Large B-cell, DiffuseUnited States, Canada, Germany
-
Calithera Biosciences, IncWithdrawnLymphoma, Malignant | Advanced Solid NeoplasmsUnited States
-
Calithera Biosciences, IncTerminatedLymphoma, Non-Hodgkin | Lymphoma, Follicular, Marginal ZoneKorea, Republic of, Japan
-
Calithera Biosciences, IncTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
Calithera Biosciences, IncCompletedBreast NeoplasmsUnited States, Spain
-
Calithera Biosciences, IncCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditionsUnited States
-
Calithera Biosciences, IncCompletedCardiac SafetyUnited Kingdom
-
Calithera Biosciences, IncCompletedAcute Myeloid Leukemia (AML) | Acute Lymphocytic Leukemia (ALL)United States
-
Calithera Biosciences, IncCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, United Kingdom, Australia, France, Italy, Germany, Spain, New Zealand
-
Calithera Biosciences, IncTerminatedDiffuse Large B-cell LymphomaSpain, United States, Italy, Canada, France, United Kingdom
-
Calithera Biosciences, IncTerminatedCarcinoma, Non-Small-Cell Lung | Advanced Solid Tumors | Triple-Negative Breast Neoplasms | Head and Neck Carcinoma, Squamous CellSpain, United States, Italy, United Kingdom
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
Calithera Biosciences, IncTerminatedAdvanced Nonhematological NeoplasmsKorea, Republic of, Japan, Taiwan
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Calithera Biosciences, IncCompletedClear Cell Renal Cell CarcinomaUnited States
-
Calithera Biosciences, IncCompletedCystic FibrosisUnited States, Canada
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
Calithera Biosciences, IncCompletedHealthy VolunteersUnited States
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
Calithera Biosciences, IncNovotech (Australia) Pty LimitedCompleted
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, IncNot yet recruiting
-
Bradley A. McGregor, MDCalithera Biosciences, IncActive, not recruitingRenal Cell CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Calithera Biosciences, IncActive, not recruitingMetastatic Colorectal Cancer | Colorectal Cancer | RAS Wild Type Colorectal Cancer | Refractory Colorectal CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Calithera Biosciences, IncNot yet recruitingCervical Cancer | Cervix Cancer | Advanced Cervical Carcinoma | Cancer of the CervixUnited States
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
LigaChem Biosciences, Inc.AntibodyChem Biosciences, Inc.RecruitingAdvanced Solid TumorsUnited States, Canada
-
IGM Biosciences, Inc.RecruitingSystemic Lupus Erythematosus | Lupus ErythematosusUnited States, Korea, Republic of, Poland
-
Neodyne Biosciences, Inc.RecruitingInsulin Resistance | LipohypertrophyGermany
-
Arcus Biosciences, Inc.RecruitingCervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Bladder Cancer | Advanced Cancer | Non-Small Cell Lung Cancer (NSCLC) | Advanced Malignancies | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Gastroesophageal-junction...United States
-
Avidity Biosciences, Inc.RecruitingPhase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, United Kingdom, Canada
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Arcus Biosciences, Inc.RecruitingClear Cell Renal Cell Carcinoma | Solid TumorsKorea, Republic of, United States
-
LegoChem Biosciences, IncRecruitingMRSA BacteremiaKorea, Republic of
-
Cogent Biosciences, Inc.RecruitingMetastatic Cancer | Advanced Gastrointestinal Stromal TumorsUnited States, Korea, Republic of, Spain, United Kingdom, Australia, France, Italy, Netherlands, Taiwan, Germany, Denmark, Hong Kong, Canada, Sweden, Norway, Mexico, Czechia, Argentina, Hungary, Brazil, Chile, Poland
-
Senhwa Biosciences, Inc.RecruitingAdvanced Solid TumorUnited States, Canada
-
FlightPath Biosciences, Inc.RecruitingLyme DiseaseUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
IGM Biosciences, Inc.RecruitingSarcoma | Acute Myeloid Leukemia | Colorectal Cancer | Solid Tumor | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chondrosarcoma | Small Lymphocytic LymphomaUnited States, Korea, Republic of, France, Spain, Australia
-
LigaChem Biosciences, Inc.Active, not recruitingMycobacterium Abscessus Infection | Nontuberculous Mycobacterium InfectionKorea, Republic of
-
Scioto Biosciences, Inc.Completed